Overview

Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of dimebon given to Alzheimer's disease patients currently on a stable dose and regimen of memantine or memantine plus donepezil.
Phase:
Phase 1
Details
Lead Sponsor:
Medivation, Inc.
Treatments:
Donepezil
Memantine